Please Wait...

A global network of investigator sites
focused on making your clinical trial a success.

SIMPLIFYING COMPLEXITY. PROVIDING CLARITY.

The Bioclinica Research Network simplifies the complexity and solves the challenges associated with clinical trials through a global network of established, readily-available investigator sites. As the preferred provider for many of the largest sponsors, CROs, and biotech companies across the globe, we handle Phase I-Phase IV studies, and are capable of taking a first-in-human drug all the way through to post-marketing.

Our sites are unified by best-in-class recruitment practices and globalized standard operating procedures (SOPs) and quality systems, yielding the highest quality of data. Each site is staffed by medical experts and trained professionals – therapeutic area specialists, physicians, nurses, study coordinators, raters, and technicians – and has a full array of medical testing equipment.

We bring you more than sites. We bring you a solution.

LEARN MORE

Research Network

The Bioclinica Advantage

Through our global network of sites, you are assured:

Fast Delivery

We enroll, care for, and retain high numbers of patients, resulting in faster study completion

Superior Quality

We generate predictable, reliable, world-class data that is inspection-ready

Cost Savings

We enable you to complete studies with fewer sites, reducing the overall time and costs of study delivery

Leverage Bioclinica's Expertise

Contact us for more information or to speak with us about how we can support you.

CONTACT US Download Brochure

Bioclinica Research Network by the Numbers

30
Dedicated Research Sites

in 14 countries across 4 continents

15000
Patients Randomized

in the last 5 years

93
Average

Patient Retention Rate

1
Potential Patients

through databases and patient communities

25000
Patient spaces

across the global network

0
Critical Findings

in sponsor and regulatory audits

Centralized Management & Processes

Our project managers are trained in clinical development and provide a single, central point of contact, visibility into study start up, and ongoing management of clinical site activities.

Centralized Management & Processes

Global Sites

With a geographic spread throughout the U.S., Europe, Latin America, and Asia, we bring you the most diverse standardized global site network in the industry. Each of our investigator sites is:

  • Structured to optimize the conduct of clinical research
  • Strategically located to take advantage of access to patient populations
  • Outfitted with state-of-the-art medical testing equipment
  • Staffed by physicians, nurses, study coordinators, technicians and other medical professionals and personnel with therapeutic area specialization

LEARN MORE

Global Sites

Leverage Bioclinica's Expertise

Contact us for more information or to speak with us about how we can support you.

CONTACT US Download Brochure

Patient Focus

In clinical trials, the patient is the number one priority.

Bioclinica maintains an extensive and dynamic patient database as well as multi-faceted patient communities – all of which can be expertly tapped through our propriety applications and our unique online and social media strategies. We have recruited and managed patients for multiple large studies, and can uncover the right patients for your clinical trials rapidly.

Patient Focus

Long-Term Retention

Clinical trials depend on the long-term retention of patients to ensure high-quality data and successful outcomes. You simply cannot afford to have high percentages of patients lost to follow-up. We have extensive experience retaining patients in studies for up to 10 years. Due to the systematic processes and patient-centric care we have in place, more than 90% of the patients we recruit remain active throughout the course of the study.

Best-in-Class Sites

Our sites are capable of managing large volumes of patients efficiently and cost-effectively, increasing patient retention rates. And because our network is unified by globalized standard operating procedures (SOPs) and quality systems, you gain clarity and insight from high-quality, audit-ready data that will drive your trial to a successful outcome.

Specialized Patient Care

Standards of care vary greatly by country, with many patients having no access to quality healthcare treatment. We provide all patients with a general examination that can result in the identification and treatment of problem areas, e.g., blood pressure or renal health. Our staff includes physicians, internal medicine experts, and other specialists to deliver the high level of care patients need. This translates into a positive overall patient experience that yields high rates of patient retention.

Real-Time Information

Through sophisticated technology, we are able to track the patient’s path all the way through your clinical trial. We will provide you with weekly reports that give excellent visibility into the management of the study at our research sites.

Therapeutic Expertise

Extensive capabilities, experience and expertise to bring clarity to clinical trials.

Over the past two decades, Bioclinica's Research Network has delivered outstanding results for Phase 1-4 clinical trials in a multitude of therapeutic areas. We provide:

  • Qualified patients, having randomized more than 15,000 patients in the last five years alone.
  • Management and care in our outpatient and inpatient facilities for a successful clinical trial.
  • Extensive capabilities to perform clinical research and bring clarity to clinical trials and drug development.

Our therapeutic expertise encompasses all the following outpatient indications:

Expert People

Everyone on staff at the Research Network is committed to clinical research. Therapeutic area specialists, physicians, study nurses, study coordinators, raters, and technicians around the world are highly trained to global standards in order to deliver exceptional service throughout the course of your clinical trial.

Key Opinion Leaders

In addition to our in-house capabilities, we invest in external Key Opinion Leaders (KOLs) to ensure that your research is successful. Our KOLs include:


Roger Bullock, MB.BS, MRCPsych

 

Key Opinion Leader

Research Network


Hans Christian Hoeck, Ph.D.

Managing Director & Chief Scientific Officer

Research Network


Craig Curtis, MD, CPI

Chief Medical Officer,
Compass Research

Research Network


Ira Goodman, MD

Key Opinion Leader

Research Network

Leverage Bioclinica's Expertise

Contact us for more information or to speak with us about how we can support you.

CONTACT US Download Brochure

Exceptional Quality

Standardized, global, validated SOPs support the highest-quality data.

Quality is at the center of all we do. You benefit from our professional Quality Assurance organization, which oversees all operations to confirm the highest-quality data for your study. All sites follow validated SOPs and detailed training programs so that clinical research is conducted to the same high standards of quality and compliance across the globe.

End-to-End Quality

  • Rigorous compliance. All clinical trial activities are conducted in compliance with ICH/GCP guidelines, the Clinical Trial Directive, relevant local regulations and guidelines, and the clinical trial’s specific requirements.
  • Local quality control. Every research center has a Local Quality Control unit that reports directly to the Director of Quality Assurance.
  • Daily quality management. On a day-to-day basis, Central Quality Assurance personnel, in conjunction with Local Quality Control, manage quality at the sites.
  • Internal audits. A team of Quality Assurance Auditors regularly conducts internal audits as part of our Quality Management System.
  • Standardized SOPs. All sites follow standardized, global, validated SOPs.

Patient Recruitment & Retention

Uncover the right patients for your clinical trials.

In clinical trials, the patient is the number one priority. That is why we treat every patient with care and respect – from recruitment to trial completion. With databases and online communities generating more than one million potential patients to draw on, we are able to fill your patient pipeline quickly with fewer sites, saving you both time and money. And, perhaps most importantly, our staff always treats patients as people – not as projects or as sources of data – keeping retention rates high throughout the course of your study.

Patient Recruitment & Retention

Streamlined Recruitment

Bioclinica maintains an extensive and dynamic global patient database and more than 50 online patient communities with over 3M unique visitors weekly—all of which can be expertly tapped to inform, engage, educate and connect the right patients with your clinical trial rapidly.

Long-Term Retention

Clinical trials depend on the long-term retention of patients to ensure high-quality data and successful outcomes. You simply cannot afford to have high percentages of patients lost to follow-up. We have extensive experience retaining patients in studies for up to 10 years. Due to the systematic processes and patient-centric care we have in place, more than 90% of the patients we recruit remain active throughout the course of the study.

Best-In-Class Sites

Our sites are capable of managing large volumes of patients efficiently and cost-effectively, increasing patient retention rates. And because our network is unified by globalized standard operating procedures (SOPs) and quality systems, you gain clarity and insight from high-quality, audit-ready data that will drive your trial to a successful outcome.

Specialized Patient Care

Standards of care vary greatly by country, with many patients having no access to quality healthcare treatment. We provide all patients with a general examination that can result in the identification and treatment of problem areas, e.g., blood pressure or renal health. Our staff includes physicians, internal medicine experts, and other specialists to deliver the high level of care patients need. This translates into a positive overall patient experience that yields high rates of patient retention.

Real-Time Information

Through sophisticated technology, we are able to track the patient’s path all the way through your clinical trial. We will provide you with weekly reports that give excellent visibility into the management of the study at our research sites.

Leverage Bioclinica's Expertise

Contact us for more information or to speak with us about how we can support you.

CONTACT US Download Brochure

Cardiovascular

Cardiovascular outcome studies have become a standard part of the development of many therapeutic areas and can involve tens of thousands of patients. Bioclinica is positioned and experienced to recruit patients in the numbers required for cardiovascular outcome studies, and to manage the studies for optimal results.

Click here for downloadable information sheet.

Endocrinology

Using a proven, systematic approach, Bioclinica is expanding its capabilities in running endocrine studies. We have successfully conducted studies in South America and China for years, and have access to a large pool of qualified patients at the global level. Our sites are capable of managing large volumes of patients efficiently and cost-effectively, increasing patient retention rates.

Click here for downloadable information sheet.

Osteoarthritis

Bioclinica has conducted 63 OA studies, ranging from Phase I to Phase IV. Over the course of these studies, we have worked with a variety of compounds and routes of administration, including ultrasound-guided intra-articular administration. Site staff are familiar with multiple OA assessment questionnaires, such as WOMAC, PGA, and PD-Q. Our Key Opinion Leader in OA has published multiple papers on the topic, leading to a greater understanding of the disease and its treatment.

Click here for downloadable information sheet.

Pain

Bioclinica has conducted 34 pain-oriented studies for OA and migraine conditions, ranging from Phase I to Phase IV. Over the course of these studies, we have worked with a variety of compounds and routes of administration, including ultrasound-guided intra-articular administration. Site staff are familiar with multiple pain assessment questionnaires, such as WOMAC, PGA, and PD-Q.

Type II Diabetes

With 180 potential treatments in development for diabetes and related conditions, recruitment of patients can be a major challenge. With over 40 diabetes studies and an average of 24 randomized patients per site under our belt, Bioclinica is able to find the patients you need – and care for them throughout the course of your study.

Click here for downloadable information sheet.

Vaccines

Over the past five years, Bioclinica has contributed to 25+ vaccine trials with superior retention rates. We are well-positioned to find qualified participants for vaccine studies as our sites operate in 14 countries across four continents: Europe, North America, South America, and Asia, with a dedicated SMO service in China that is focused on delivery of qualified patients. Because our network covers both the northern and southern hemispheres, we are able to help you find qualified subjects at any time and in any location. You can therefore address seasonal illnesses (such as the flu) around the world in a timely manner.

Click here for downloadable information sheet.

ADDITIONAL RESOURCES

Research Network

Download Brochure

Alzheimer's Disease

Download Info Sheet

Cardiovascular Outcome Studies

Download Info Sheet

Endo-Diabetes

Download Info Sheet

Vaccine Development

Download Info Sheet

7 ADVANTAGES OF A SITE NETWORK

Download Slideshow

Osteoarthritis Expertise

Download Info Sheet

Global Clinical Research

Download Brochure

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

Our Medical Imaging team is in the spotlight for a job well done! https://t.co/fkmt0zvPhf https://t.co/D7YMTeiSd3
bioclinica (2 days ago)
RT @melfass: "What this agreement means is that we can allocate scarce resources to areas of higher risk" @US_FDA on MRA with @EMA_News at…
bioclinica (3 days ago)
RT @DrugInfoAssn: What has been the biggest takeway for your organization so far? Tweet @ us using #DIA2017
bioclinica (5 days ago)
"Q" on #RBM & Total Quality Mgmt? @Kristin_Mauri has "A" @DrugInfoAssn #DIA2017 https://t.co/MqCxkmAfa0
bioclinica (5 days ago)
Kristen Mauri shows the @DIA audience the value of risk based monitoring https://t.co/ssJCfc9gQ5
bioclinica (5 days ago)
Innovation Theater Kristin Mauri of @bioclinica presenting on RBM & TQM @DrugInfoAssn #DIA2017 https://t.co/zsGroQcpiU
bioclinica (5 days ago)

Latest Blogs: